Thomas Stephan
Stock Analyst at Stifel
(1.49)
# 3,492
Out of 5,044 analysts
47
Total ratings
36.67%
Success rate
-5.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALC Alcon | Maintains: Buy | $90 → $85 | $75.50 | +12.58% | 5 | Sep 29, 2025 | |
| TMDX TransMedics Group | Initiates: Hold | $115 | $132.92 | -13.48% | 1 | Sep 4, 2025 | |
| STAA STAAR Surgical Company | Downgrades: Hold | $20 → $28 | $27.80 | +0.72% | 10 | Aug 7, 2025 | |
| GKOS Glaukos | Maintains: Buy | $140 → $115 | $74.41 | +54.55% | 9 | May 1, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $8.53 | +228.25% | 10 | Mar 19, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $4 | $5.14 | -22.18% | 7 | Mar 6, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $15.29 | +17.72% | 3 | Jan 29, 2025 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.05 | +90.48% | 2 | May 15, 2024 |
Alcon
Sep 29, 2025
Maintains: Buy
Price Target: $90 → $85
Current: $75.50
Upside: +12.58%
TransMedics Group
Sep 4, 2025
Initiates: Hold
Price Target: $115
Current: $132.92
Upside: -13.48%
STAAR Surgical Company
Aug 7, 2025
Downgrades: Hold
Price Target: $20 → $28
Current: $27.80
Upside: +0.72%
Glaukos
May 1, 2025
Maintains: Buy
Price Target: $140 → $115
Current: $74.41
Upside: +54.55%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $8.53
Upside: +228.25%
Sight Sciences
Mar 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $5.14
Upside: -22.18%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $15.29
Upside: +17.72%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.05
Upside: +90.48%